Medicure Inc. (MCUJF)


Other OTC - Other OTC Delayed Price. Currency in USD
4.86-0.03 (-0.63%)
As of 2:54 PM EDT. Market open.
People also watch:
MHGUMSLIANTBBLUSFFSRL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open4.83
Prev Close4.89
Bid0.00 x
Ask0.00 x
Day's Range4.83 - 4.86
52wk Range4.56 - 5.37
1y Target EstN/A
Market Cap74.93M
P/E Ratio (ttm)45.84
Beta1.18
Volume1,066
Avg Vol (3m)2,292
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Medicure, Inc. : Overvalued relative to peers, but may deserve another look
    Capital Cube17 days ago

    Medicure, Inc. : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo Finance Medicure, Inc. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 97. Our analysis is based on comparing Medicure, Inc. with the following peers – Cardiome Pharma Corp., Resverlogix Corp., Merck & Co., Inc., Medicines Company, Eli Lilly and Company, Eiger BioPharmaceuticals, Inc. and Tobira Therapeutics, Inc. ... Read more (Read more...)

  • PR Newswire2 months ago

    Medicure Reports Second Quarter 2016 Financial Results

    WINNIPEG, Aug. 10, 2016 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today reported its results from operations ...

  • CNW Group2 months ago

    Medicure Reports Second Quarter 2016 Financial Results

    Medicure Reports Second Quarter 2016 Financial Results